Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide.
Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries.
